Level 3 · Human studyClinical trial

Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results

Waugh WH, Daeschner CW, Files BA, McConnell ME, Strandjord SE

Journal of the National Medical Association · 1 October 2001

AUTHORS’ ABSTRACT

The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.

Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.

← All studies